April 13, 2020

Blueprint for a Pop-up SARS-CoV-2 Testing Lab

Category: Article Summary

Topic: Testing and Treatment

• The Innovative Genomics Institute SARS-CoV-2 Testing Consortium describe the strategy they used to establish a CLIA-licensed clinical laboratory to perform a validated Laboratory-Developed Test (LDT) for SARS-CoV-2 in Berkeley, California and the surrounding Bay Area community. The procedures for implementing the technical, regulatory, and data management work streams necessary for clinical sample processing provide a roadmap to aid others in setting up similar testing centers.

Innovative Genomics Institute SARS-CoV-2 Testing Consortium. (April 12 2020). Blueprint for a Pop-up SARS-CoV-2 Testing Lab. Pre-print downloaded Apr 13 from https://doi.org/10.1101/2020.04.11.20061424